Connection

David Hoel to Animals

This is a "connection" page, showing publications David Hoel has written about Animals.
Connection Strength

0.501
  1. A sterile insect technique pilot trial on Captiva Island: defining mosquito population parameters for sterile male releases using mark-release-recapture. Parasit Vectors. 2022 Nov 01; 15(1):402.
    View in: PubMed
    Score: 0.061
  2. Cardiovascular effects of fission neutron or 60Co ? exposure in the B6CF1 mouse. Int J Radiat Biol. 2017 06; 93(6):563-568.
    View in: PubMed
    Score: 0.041
  3. Comments on the DDREF estimate of the BEIR VII Committee. Health Phys. 2015 Mar; 108(3):351-6.
    View in: PubMed
    Score: 0.036
  4. Determining the relative toxicity and RBE of internal emitters in animals. Health Phys. 2010 Sep; 99(3):367-70.
    View in: PubMed
    Score: 0.026
  5. Lung, liver and bone cancer mortality after plutonium exposure in beagle dogs and nuclear workers. Health Phys. 2010 Jan; 98(1):42-52.
    View in: PubMed
    Score: 0.025
  6. Lung fibrosis and lung cancer incidence in beagle dogs that inhaled 238PuO2 or 239PuO2. Health Phys. 2009 Apr; 96(4):493-503.
    View in: PubMed
    Score: 0.024
  7. Ionizing radiation and cardiovascular disease. Ann N Y Acad Sci. 2006 Sep; 1076:309-17.
    View in: PubMed
    Score: 0.020
  8. Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol. Environ Health Perspect. 2006 Aug; 114(8):1237-42.
    View in: PubMed
    Score: 0.020
  9. Mortality of atomic bomb survivors predicted from laboratory animals. Radiat Res. 2003 Aug; 160(2):159-67.
    View in: PubMed
    Score: 0.016
  10. Guidance on radiation dose limits for the lens of the eye: overview of the recommendations in NCRP Commentary No. 26. Int J Radiat Biol. 2017 10; 93(10):1015-1023.
    View in: PubMed
    Score: 0.010
  11. The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation. Int J Radiat Biol. 2016 08; 92(8):405-26.
    View in: PubMed
    Score: 0.010
  12. Synergism between sinusoidal-50?Hz magnetic field and formaldehyde in triggering carcinogenic effects in male Sprague-Dawley rats. Am J Ind Med. 2016 07; 59(7):509-21.
    View in: PubMed
    Score: 0.010
  13. Life-span exposure to sinusoidal-50?Hz magnetic field and acute low-dose ? radiation induce carcinogenic effects in Sprague-Dawley rats. Int J Radiat Biol. 2016; 92(4):202-14.
    View in: PubMed
    Score: 0.010
  14. Nonlinearity of dose-response functions for carcinogenicity. Environ Health Perspect. 1994 Jan; 102 Suppl 1:109-13.
    View in: PubMed
    Score: 0.008
  15. Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: scientific and public health impact. Fundam Appl Toxicol. 1993 May; 20(4):413-36.
    View in: PubMed
    Score: 0.008
  16. Concordance of carcinogenic response between rodent species: potency dependence and potential underestimation. Risk Anal. 1992 Mar; 12(1):115-21.
    View in: PubMed
    Score: 0.007
  17. Perspective and overview of the concepts and value of hazard identification as the initial phase of risk assessment for cancer and human health. Scand J Work Environ Health. 1992; 18 Suppl 1:83-9.
    View in: PubMed
    Score: 0.007
  18. A balanced approach to risk assessment. Toxicol Ind Health. 1991 Sep-Nov; 7(5-6):305-11.
    View in: PubMed
    Score: 0.007
  19. Assumptions of the HERP Index. Risk Anal. 1990 Dec; 10(4):623-4; discussion 629-33.
    View in: PubMed
    Score: 0.007
  20. Relative toxicity of (45)Ca beta-particles and (242)Cm alpha-particles following their intravenous injection into mice as radiolabelled FAP. Int J Radiat Biol. 2010 Apr; 86(4):300-20.
    View in: PubMed
    Score: 0.006
  21. Benzene risk assessments: review and update. Cell Biol Toxicol. 1989 Nov; 5(3):287-95.
    View in: PubMed
    Score: 0.006
  22. Metabolite-based internal doses used in a risk assessment of benzene. Environ Health Perspect. 1989 Jul; 82:177-84.
    View in: PubMed
    Score: 0.006
  23. Trichloroethylene risk assessment: a review and commentary. Crit Rev Toxicol. 2009; 39(9):782-97.
    View in: PubMed
    Score: 0.006
  24. The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis. 1988 Nov; 9(11):2045-52.
    View in: PubMed
    Score: 0.006
  25. Exploring relationships between mutagenic and carcinogenic potencies. Mutat Res. 1988 Sep; 196(2):161-75.
    View in: PubMed
    Score: 0.006
  26. Issues concerning the estimation of the TD50. Risk Anal. 1987 Dec; 7(4):437-47.
    View in: PubMed
    Score: 0.005
  27. Radiation risk estimation models. Environ Health Perspect. 1987 Nov; 75:105-7.
    View in: PubMed
    Score: 0.005
  28. Evidence of health impacts of sulfate-and nitrate-containing particles in ambient air. Inhal Toxicol. 2007 May; 19(5):419-49.
    View in: PubMed
    Score: 0.005
  29. Relative toxicity of chronic irradiation by 45Ca beta particles and 242Cm alpha particles with respect to the production of lung tumors in CBA/Ca mice. Radiat Res. 2006 Nov; 166(5):782-93.
    View in: PubMed
    Score: 0.005
  30. Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments. Cancer Res. 1986 Sep; 46(9):4372-8.
    View in: PubMed
    Score: 0.005
  31. Statistical modeling of animal bioassay data with variable dosing regimens: example--vinyl chloride. Risk Anal. 1986 Jun; 6(2):155-66.
    View in: PubMed
    Score: 0.005
  32. An empirical comparison of methods used to estimate carcinogenic potency in long-term animal bioassays: lifetable vs summary incidence data. Fundam Appl Toxicol. 1986 Feb; 6(2):263-9.
    View in: PubMed
    Score: 0.005
  33. Toxicity and carcinogenic potency. Risk Anal. 1985 Dec; 5(4):263-4.
    View in: PubMed
    Score: 0.005
  34. Use of historical controls for animal experiments. Environ Health Perspect. 1985 Nov; 63:217-24.
    View in: PubMed
    Score: 0.005
  35. Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. Fundam Appl Toxicol. 1985 Feb; 5(1):79-86.
    View in: PubMed
    Score: 0.004
  36. Design of animal carcinogenicity studies for goodness-of-fit of multistage models. Fundam Appl Toxicol. 1984 Dec; 4(6):949-59.
    View in: PubMed
    Score: 0.004
  37. Nonparametric estimation of the survival function when cause of death is uncertain. Biometrics. 1984 Dec; 40(4):1151-8.
    View in: PubMed
    Score: 0.004
  38. Modeling time-to-tumor data: analysis of the ED01 study. Fundam Appl Toxicol. 1983 Sep-Oct; 3(5):458-69.
    View in: PubMed
    Score: 0.004
  39. Multistage prediction of cancer in serially dosed animals with application to the ED01 study. Fundam Appl Toxicol. 1983 Sep-Oct; 3(5):470-7.
    View in: PubMed
    Score: 0.004
  40. Optimal design of the chronic animal bioassay. J Toxicol Environ Health. 1983 Jul; 12(1):1-19.
    View in: PubMed
    Score: 0.004
  41. Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science. 1983 Mar 04; 219(4588):1032-7.
    View in: PubMed
    Score: 0.004
  42. Statistical measures of risk. Drug Metab Rev. 1982; 13(5):829-38.
    View in: PubMed
    Score: 0.004
  43. Incorporation of background in dose-response models. Fed Proc. 1980 Jan; 39(1):73-5.
    View in: PubMed
    Score: 0.003
  44. Statistical approaches to toxicological data. Environ Health Perspect. 1979 Oct; 32:267-71.
    View in: PubMed
    Score: 0.003
  45. Statistical design of toxicity assays: role of genetic structure of test animal population. J Environ Pathol Toxicol. 1979 Jul-Aug; 2(6):1313-27.
    View in: PubMed
    Score: 0.003
  46. Statistical design of toxicity assays: role of genetic structure of test animal population. J Toxicol Environ Health. 1979 Jan; 5(1):89-101.
    View in: PubMed
    Score: 0.003
  47. Recent data obtained by pulsed-field gel electrophoresis suggest two types of double-strand breaks. Radiat Res. 1998 Jan; 149(1):52-8.
    View in: PubMed
    Score: 0.003
  48. The effect of dose on cancer latency period. J Environ Pathol Toxicol. 1977 Nov-Dec; 1(2):279-86.
    View in: PubMed
    Score: 0.003
  49. Occupational carcinogenesis. Statistical extrapolation methods for estimating risks from animal data. Ann N Y Acad Sci. 1976; 271:418-20.
    View in: PubMed
    Score: 0.002
  50. Estimation of risks of irreversible, delayed toxicity. J Toxicol Environ Health. 1975 Sep; 1(1):133-51.
    View in: PubMed
    Score: 0.002
  51. Ligand/receptor binding for 2,3,7,8-TCDD: implications for risk assessment. Fundam Appl Toxicol. 1993 Jan; 20(1):48-56.
    View in: PubMed
    Score: 0.002
  52. Statistical analysis of survival experiments. J Natl Cancer Inst. 1972 Aug; 49(2):361-72.
    View in: PubMed
    Score: 0.002
  53. A representation of mortality data by competing risks. Biometrics. 1972 Jun; 28(2):475-88.
    View in: PubMed
    Score: 0.002
  54. Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine. Cancer Res. 1991 Dec 01; 51(23 Pt 2):6409-14.
    View in: PubMed
    Score: 0.002
  55. Regulation of tyrosine alpha-ketoglutarate transaminase in rat liver. IX. Studies of the mechanisms of hormonal inductions in cultured hepatoma cells. J Biol Chem. 1970 Nov 10; 245(21):5806-12.
    View in: PubMed
    Score: 0.002
  56. Biologically based models for risk assessment. IARC Sci Publ. 1990; (104):20-8.
    View in: PubMed
    Score: 0.002
  57. Some practical problems arising from use of the gamma multihit model for risk estimation. J Toxicol Environ Health. 1981 Sep; 8(3):379-86.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.